Lin Gao

No. 305 Zhongshan East Road
Nanjing, 210002, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Glycerol-mediated nose-to-brain codelivery of anti-IL-17 and anti-CD73 antibodies enhances immunotherapy for melanoma brain metastases.

Glycerol-mediated nose-to-brain codelivery of anti-IL-17 and anti-CD73 antibodies enhances immunotherapy for melanoma brain metastases.

Journal: Science advances

Published: May 13, 2026

CFD Investigation of the Effect of Condensation Chamber Geometry on Nanoparticle Transport in Magnetron Sputtering.

CFD Investigation of the Effect of Condensation Chamber Geometry on Nanoparticle Transport in Magnetron Sputtering.

Journal: Nanomaterials (Basel, Switzerland)

Published: April 03, 2026

The use of sivelestat sodium among patients with acute pancreatitis and early organ failure: a single-center retrospective cohort study.

The use of sivelestat sodium among patients with acute pancreatitis and early organ failure: a single-center retrospective cohort study.

Journal: Frontiers in medicine

Published: March 27, 2026

The effect of pectin-supplemented enteral nutrition in mechanically ventilated patients receiving gastric feeding: protocol of a multicenter, open-label, randomized controlled trial (the PROMOTE trial).

The effect of pectin-supplemented enteral nutrition in mechanically ventilated patients receiving gastric feeding: protocol of a multicenter, open-label, randomized controlled trial (the PROMOTE trial).

Journal: Frontiers in medicine

Published: February 24, 2026

Enhancing Breast Cancer Immunotherapy by Suppressing Sympathetic Nervous System-Driven T-Cell Exhaustion and Promoting T-Cell Priming and Trafficking.

Enhancing Breast Cancer Immunotherapy by Suppressing Sympathetic Nervous System-Driven T-Cell Exhaustion and Promoting T-Cell Priming and Trafficking.

Journal: ACS nano

Published: December 23, 2025

Inhibition of a Disintegrin and Metalloproteinase With Thrombospondin Type 1 Motif, Member 13 Activity by Peptidylarginine Deiminase IV Exacerbates Pancreatic Necrosis in Acute Pancreatitis.

Inhibition of a Disintegrin and Metalloproteinase With Thrombospondin Type 1 Motif, Member 13 Activity by Peptidylarginine Deiminase IV Exacerbates Pancreatic Necrosis in Acute Pancreatitis.

Journal: Cellular and molecular gastroenterology and hepatology

Published: November 25, 2025

No benefit, or no power? The TIMING trial between Atlanta classification and SOFA score for severe acute pancreatitis: author's reply.

No benefit, or no power? The TIMING trial between Atlanta classification and SOFA score for severe acute pancreatitis: author's reply.

Journal: Intensive care medicine

Published: November 06, 2025

Low-intensity pulsed ultrasound-mediated nose-to-brain co-delivery of β-blockers and aPD-L1 enhances glioblastoma immunotherapy.

Low-intensity pulsed ultrasound-mediated nose-to-brain co-delivery of β-blockers and aPD-L1 enhances glioblastoma immunotherapy.

Journal: Nature communications

Published: October 16, 2025

Prognostic significance of heart rate trajectories on organ failure in predicted severe acute pancreatitis: secondary analysis of a randomized trial.

Prognostic significance of heart rate trajectories on organ failure in predicted severe acute pancreatitis: secondary analysis of a randomized trial.

Journal: Scientific reports

Published: September 28, 2025

Engineered macrophage membrane-mimicking nanodrugs activate cGAS/STING pathway to reverse tumor immune suppression after incomplete radiofrequency ablation.

Engineered macrophage membrane-mimicking nanodrugs activate cGAS/STING pathway to reverse tumor immune suppression after incomplete radiofrequency ablation.

Journal: Journal of nanobiotechnology

Published: September 11, 2025

Enhancing TIM-3 immunotherapy with epirubicin-loaded pH sensitive fusion membrane nanoparticles for effective glioblastoma treatment.

Enhancing TIM-3 immunotherapy with epirubicin-loaded pH sensitive fusion membrane nanoparticles for effective glioblastoma treatment.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: September 01, 2025

Co-delivering macrophage engager mRNA and PD-L1 antibody via tumor-responsive nanoparticles for glioblastoma immunotherapy.

Co-delivering macrophage engager mRNA and PD-L1 antibody via tumor-responsive nanoparticles for glioblastoma immunotherapy.

Journal: Nature communications

Published: August 14, 2025

Showing 1-12 of 63

Last Updated: 09/26/2026